WHO vaccine-preventable diseases: monitoring system. 2015 global summary

Last updated 28-May-2015 (Data received as of 22-May-2015)
Next overall update July 2015
2014 data are provisional
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 6701 Infant (under 12 months) mortality rate: 802
GDP / capita (US$): 1'6411 Child (under 5 years) mortality rate: 1282

Population data in thousands3

  2014  2013  2012  2011  2010  2000  1990  1980 
Total population 15'768  15'302  14'854  14'417  13'986  10'261  7'964  6'735 
Births 742  723  705  687  668  496  384  331 
Surviving infants 680  661  643  624  606  440  333  279 
Pop. less than 5 years 3'037  2'951  2'865  2'774  2'675  1'919  1'468  1'203 
Pop. less than 15 years 7'489  7'252  7'018  6'783  6'545  4'730  3'690  2'927 
Female 15-49 years 3'442  3'344  3'251  3'164  3'081  2'260  1'726  1'513 

Number of reported case

(Click for retrospective incidence data for Mali)
Diphtheria 143 
Japanese encephalitis
Measles 290  221  341  24  1'719  1'578  1'388  10'007 
Mumps
Pertussis 430  2'811 
Polio* 63  234 
Rubella 19  19  19  125  64 
Rubella (CRS)
Tetanus (neonatal) 13  12  10  11  73  203 
Tetanus (total)** 61  37  108  86  168  365  294 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For desagregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Mali)
Vaccine year result method % card seen                                                
BCG 2011  84  DHS   38  84  89  99*  99*  97  82  82 
DTP1 2011  80  DHS   38  85  86  99*  99*  61 
DTP3 2011  63  DHS   38  81  76  90  88  92  54  42 
HepB_BD         
HepB3 2011  63  DHS   38  81  76  90  88  92 
Hib3 2011  63  DHS   38  81  76  90  88  92 
JapEnc         
MCV          72  72  85  82  89  55  43 
MCV2         
PCV1          85  86  99*  99* 
PCV3          79  76  87  56 
Pol3 2011  50  DHS   38  85  79  90  87  89  54  42 
Rota1          20 
Rota_last          13 
Rubella1         
TT2plus 2008  47  MICS   59  86  95  66  60  59  62  37 
PAB         
VAD1          81  73 
YFV 2011  28  DHS   38  73  75  84  81  88 
  ° indicates that more than 1 survey occurred that year

  Next update: July 2015

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Mali)
BCG 87  87  87  84  69  82 
DTP1 82  82  82  82  61  67 
DTP3 74  74  72  76  43  42 
HepB3 74  74  72  76 
HepB_BD
Hib3 74  74  72  76 
MCV 72  72  69  76  49  43 
MCV2
PAB 85  89  89  85  50  45 
PCV3 74  74  56 
Pol3 81  81  78  80  53  42 
Rota_last
YFV 62  71  68  75  11 

Number of districts in the country 63  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
95 
   
/
|
|
\
Greater or equal to 90% 75
From 80 to 89% 14
From 50 to 79% 3
Less than 50% 5
Proportion of districts
not reporting DTP3 coverage
3
 

Immunization Schedule (2014 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
IPV 14 weeks; Yes From June 2015
Measles 9 months; Yes
OPV birth; 6, 10, 14 weeks; Yes
Pneumo_conj 6, 10, 14 weeks; Yes
Rotavirus 6, 10, 14 weeks; No
TT 1st contact pregnancy; +1, +6 months; +1, +1 year; Yes
Td 1st contact pregnancy; +1, +6 months; +1, +1 years; Yes From September 2015
VitaminA 6 months; 1 year; Yes
YF 9 months; Yes

Immunizaton indicators

Indicator Expected answer 2014  2013  2012  2011  2010  2009  2008 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2012-2016  2012-2016  2012-2016  2012-2016  2007-2011  2007-2011  2007 - 2011 
Nº of districts with microplans that include activities to raise immunization coverage number 63  60  60    59  59  59 

System performance

Total Nº districts in country number 63  60  60  60  59  59  59 
Nº districts with DTP3 coverage >=80% number 56  46  44  43  42  48  48 
% of districts with DTP3 coverage >=80% From 0 to 100% 89  77  73  72  71  81  81 
Nº districts with measles (MCV1) coverage >=95% number 18  17  15  10  18  34  36 
% of districts with MCV1 coverage >=95% From 0 to 100% 29  28  25  17  31  58  61 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  Yes  Yes  Yes  No     
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR No  Yes  Yes  Yes  Yes  Yes  Yes 

Finance

Immunization expenditure financed, using Government funds? From 0 to 100% 17    22  45  50 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR Yes  No  No    No     

Sources

 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2013, data for 2012
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.